# Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.

> **NCT02096315** · PHASE2 · TERMINATED · sponsor: **Polyphor Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Bronchiectasis
- Lower Respiratory Infection

## Interventions

- **DRUG:** POL7080

## Key facts

- **NCT ID:** NCT02096315
- **Lead sponsor:** Polyphor Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02096315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02096315, "Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02096315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*